Daratumumab-based regimen for newly diagnosed multiple myeloma patients with paraskeletal plasmacytomas: a retrospective study in a single center by Shuiqing Xu, Wenming Chen, Yanchen Li

Subjects: Get full text

Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study by Mauro Passucci, Francesca Fazio, Jacopo Micozzi, Manhaz Shafii Bafti, Giovanni Manfredi Assanto, Alfonso Piciocchi, Maurizio Martelli, Maria Teresa Petrucci

Subjects: “…daratumumab…”
Get full text

Daratumumab by Vishnu Gopal, Biswajit Dubashi

Subjects: Get full text

Bleeding Diathesis Secondary to a Heparin-Like Anticoagulant in a Patient with Multiple Myeloma—A Case Report and Review of Literature by Nihar Desai, Seema Biswas, Dinesh Chandra, Ruchi Gupta, Anshul Gupta, Rajesh Kashyap

Subjects: Get full text

Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma by A P Dubey, Sameer Khatri, Sachin Maggo, Nilabh K Singh, Durgesh Sharma

Subjects: Get full text

Delayed diagnosis of POEMS syndrome, how AI tools can enhance diagnostic accuracy by Max Jin, Sowbharnika Arivazhagan, Prerna Mewawalla, Santhosh Sadashiv, Arjun Lakshman

Subjects: Get full text

Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis by Hua Jiang, Lu Li, Meiyu Guo, Meizhang Li, Hao Wu, Xiaomei Chen, Mingzhao Gao, Qianqian Xu, Jia Mi, Canchan Cui, Weijun Fu

Subjects: Get full text

Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens by Danilo De Novellis, Raffaele Fontana, Bianca Serio, Emilia Vaccaro, Roberto Guariglia, Denise Morini, Michela Rizzo, Valentina Giudice, Carmine Selleri

Subjects: Get full text

Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti‐CD38 Monoclonal Antibodies: A Systematic Review by Chia Jie Tan, Dylan Kacerek, Nattawara Kampirapawong, Amandeep Godara, Nathorn Chaiyakunapruk

Subjects: “…daratumumab…”
Get full text

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cel... by Hongjie Wang, Theo Koob, Jonathan R. Fromm, Ajay Gopal, Darrick Carter, André Lieber

Subjects: Get full text

The Novel Use of Daratumumab in the Treatment of Refractory Autoimmune Pulmonary Alveolar Proteinosis by April Strong, Ying Sun, David Pilcher, Zane Kaplan, Rob G. Stirling

Subjects: Get full text

Treatment of double-refractory multiple myeloma by S. V. Semochkin

Subjects: Get full text

Daratumumab for Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allograft: A Case Report by Zewei Chen, Shangxi Fu, Jun Wu, Xiaoling Luo, Zhiguo Mao, Dechao Xu, Xiang Gao

Subjects: Get full text

Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma by Barry Paul, Jiri Minarik, Francesca Cottini, Cristina Gasparetto, Jack Khouri, Mitul Gandhi, Jens Hillengass, Moshe Levy, Michaela Liedtke, Sudhir Manda, Irwindeep Sandhu, Douglas Sborov, Ivan Spicka, Saad Usmani, Mei Dong, Lin Gu, Carmen Leung, Parul Doshi, Christine Chen, Ludek Pour

Subjects: Get full text

Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis by Jinqiao Li, Xiaoxia Li, Yueyue Fu, Hongbin Meng, Dan Xu, Wenyi Hou

Subjects: Get full text

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study by Øystein Fluge, Øystein Fluge, Ingrid Gurvin Rekeland, Kari Sørland, Kine Alme, Kristin Risa, Ove Bruland, Karl Johan Tronstad, Olav Mella

Subjects: Get full text

Restoring sensitivity to daratumumab with all-transretinoic acid in a patient with daratumumab-refractory multiple myeloma: A case report and review of the literature by Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Susan Kumka, Kimberley Doucette, Joshua Zenreich, Bianca DeAgresta, Alexandra Della Pia, Lisa Biamonte, Martha Campanaro, Trina McClendon, Samanta BaboolallAracena, Palka Anand, Adolfo Aleman, Monique Pace, Genevieve Breeze, Kristin Ivanovski, Marie Layton, David S. Siegel

Subjects: Get full text

Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—A clinical pilot study by Frontiers Production Office

Subjects: Get full text

Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review by Xiao-yu Jing, Xiao-yu Jing, Dong-jun Li, Dong-jun Li, Sheng-nan Su, Sheng-nan Su, Qing-kai Dai, Shu-wen Sun, Shu-wen Sun, Liang Huang, Yuan Ai, Yuan Ai, Ju Gao, Ju Gao, Yi-Ping Zhu, Yi-Ping Zhu, Jia-qi Ni, Jia-qi Ni, Jia-qi Ni, Xiao-xi Lu, Xiao-xi Lu

Subjects: Get full text

Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis by Decimo Silvio Chiarenza, Raul Mancini, Carolina Bigatti, Carolina Bigatti, Gianluca Caridi, Alessandro Consolaro, Alessandro Consolaro, Valentina Natoli, Valentina Natoli, Gabriele Mortari, Xhuliana Kajana, Francesca Lugani, Marco Gattorno, Marco Gattorno, Gian Marco Ghiggeri, Edoardo La Porta, Gabriele Gaggero, Enrico E. Verrina, Andrea Angeletti

Subjects: Get full text